1. Rosen FS, Wedgwood RJ, Eibl M, Griscelli C, Seligman M, Aiuti F, Kishimoto T, Matsumoto S, Khakhalin LN, Hanson LA, Hitzig WH, Thompson RA, Cooper MD, Good RA & Waldmann TA. Report of a meeting held on September 4, 1991 at Tomamu, Hokkaido, Japan. In: Rosen FS, Seligman M. eds. “Immunodeficiencies”. Harwood Academic Publishers GmbH, 1993.
2. Luzi G, Businco L & Aiuti F. Primary immunodeficiency syndromes in Italy: A report of the National Register in children and adults. J Clin Imm 1983; 3: 4.
3. Levin AS, Spitler LE, Stites DP, Fudenberg HH. Wiskott-Aldrich syndrome, a genetically determined cellular immunologic deficiency: Clinical and laboratory responses to therapy with transfer factor. Proc Acad Sci, 1970; 67: 821–28.
4. Kirkpatrick CH & Greenberg LE. Treatment of chronic mucucutaneous candidiasis with transfer factor. In: Khan A, Kirkpatrick CH, Hill NO, eds. Immune Regulators in transfer factor. New York: Academic Press, 1983: 547–62.
5. Littman BH, Rocklin RE, Parkman R & David JR. Transfer factor treatment of chronic mucocutaneous candidiasis: requirement for donor reactivity to candida antigen. Clin Imm Im 1978; 9:97–105.